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A new C1--activated aminopeptidase was purified from the cytosol of human erythrocytes a  a single chain protein of 
an approx. Mr of 70 000 and pl of 5. I. The enzyme hydrolysed 2-naphthylamides of aliphatic, aromatic and basic L-amino 
acids, with a preference for the alanyl residue. It also hydrolysed i-, tri-, and some hydrophobic tetrapeptides. The inhibi- 
tors were bestatin, amastatin, Co z+, Zn 2+, Mn 2÷, 4-hydroxymercuribenzoate and 1,10-phenanthroline. The activity of 
the enzyme, inhibited by 4-hydroxymercuribenzoate, was partially restored by the addition of sulfhydryl compounds. 
The presence of 0.2 M C1- (Br-, F-)  caused aseveral-fold increase in the isolated aminopeptidase activity. 
Aminopeptidase; Alanyl aminopeptidase; Halide activation; (Erythrocyte, Human) 
1. INTRODUCTION 
Most  o f  the mammal ian  aminopept idases  were 
recogn ized  as meta l -act ivated enzymes [1], whereas 
ac t ivat ion  by hal ide an ions  was observed only  with 
the soluble arginyl  and cystinyl aminopept idase  
[2-8]. 
We have observed that  the cytosol  o f  human 
erythrocytes  conta ins  three proteo lyt ic  enzymes 
which  c leave the aminopept idase  substrate,  
Arg -2NA.  One  of  them was isolated and 
character i zed  as an aminopept idase  o f  b road  
specif ic i ty,  act ivated by Co  2+ [9]. The  second one 
most  p robab ly  cor responds  to the enzyme iden- 
t i f ied as the ch lor ide-act ivated arginyl  aminopep-  
t idase [3,10,11]. The  present  s tudy descr ibes the 
pur i f i ca t ion  and character i zat ion  o f  the third 
Arg -2NA hydro lys ing enzyme der ived f rom the 
cytoso l  o f  human erythrocytes ,  which was shown 
to be a new alanyl  aminopept idase ,  marked ly  ac- 
t ivated by ch lor ide ions. 
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2. MATERIALS  AND METHODS 
2.1. Enzyme purification 
Fresh human erythrocytes, washed and free of white cells, 
were lysed by the addition of 5.5 vols of 5 mM sodium 
phosphate, pH 6.8. Membranes were removed by centrifuga- 
tion (1 h, 20000 x g) and cytosol (940 ml) applied (120 ml/h) 
to a DEAE-cellulose column (5 × 13 cm) equilibrated with a 
10 mM sodium phosphate buffer, pH 6.8. The column was rins- 
ed with the starting buffer, and then with 10 bed vols of a linear 
NaCl gradient (0.0-0.14 M) in the same buffer. The new 
Cl--activated aminopeptidase was eluted between 0.045 and 
0.055 M NaCl, dialysed and rechromatographed on the DEAE- 
cellulose column (0.9 x 18 cm) using a 10 mM sodium 
phosphate buffer, pH 6.9, with 1 mM 2-mercaptoethanol, and 
0.0-0.14 M NaC1 gradient. The last purification step was gel 
filtration on a Sephacryl S-200, superfine, column (2.5 × 
88 cm) in the same buffer containing 0.2 M NaC1. Enzyme 
preparation was concentrated by ultrafiltration and stored in 
40% glycerol at - 10°C. 
2.2. Enzyme and protein assay 
Aminopeptidase activity was determined in a reaction mix- 
ture containing 0.089raM Ala-2NA or another amino 
acid-2NA (Serva), 25 mM sodium phosphate buffer, pH 7.5, 
150 mM NaCl and an appropriate amount of enzyme, as 
previously described [12]. Activity of the purified aminopep- 
tidase was also determined with Ala-4Nan (0.5 M) by con- 
tinuous recording of liberated 4-nitroaniline as A405 [13]. The 
unit of activity was defined as the amount of enzyme which 
splits 1/zM of substrate per min. Proteolytic activity was 
assayed at pH 4.0, 7.5 and 8.6 by overnight incubation of 0.1 °70 
Azocoll (Sigma) with 3.5/zg/ml of the enzyme.. 
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Proteins were monitored as absorbance at280 nm or deter- 
mined by the method of Bradford [14] using bovine serum 
albumin as a standard. 
2.3. Degradation of peptides 
Aminopeptidase (2.5/zg/ml) was incubated with 0.41 mM 
peptide in 50 mM Tris-HC1, pH 7.5, for 1 h at 37°C. Aliquots 
of 5/zl were analysed by thin-layer chromatography [12] and in- 
tensities of spots compared visually with those of standards. 
2.4. Electrophoresis and isoelectric focusing 
These were performed by the PhastSystem (Pharmacia, 
Sweden) using PhastGel gradient 8-25 plates and PhastGel IEF 
3-9 plates, respectively. For the SDS-PAGE the samples were 
treated with 2.5% SDS and 5% mercaptoethanol for 5 min at 
I00°C. 
2.5. Relative molecular mass 
This was determined by SDS-PAGE, and by gel filtration on 
a Bio-Gel P-100 (Bio-Rad) column (1.6 x 86 cm) in 50 mM 
Tris-HCl buffer, pH 7.9, with 0.5 M KCI, at a flow rate of 
20 ml/h. Low Mr calibration kits from Pharmacia were used. 
3. RESULTS 
3.1. Enzyme purification 
The isolation of Cl--activated aminopeptidase 
from human erythrocytes cytosol is summarized in
table 1. By the described procedure 23000-fold 
purification was achieved, whereas the yield is 
most probably higher than 17o70, since the broad 
specificity aminopeptidase also contributes to the 
hydrolysis of AIa-2NA in the cytosol. The isolated 
enzyme was homogeneous by PAGE and IEF. 
Determination of aminopeptidase activity per- 
formed on gels after PAGE, revealed that the pro- 
tein band coincided with the area of hydrolytic 
activity. 
3.2. Enzyme characterization 
The relative molecular mass of the isolated 
aminopeptidase d termined by SDS-PAGE and by 
gel filtration was about 65000 and 72000, respec- 
tively. No subunits were detected. Its isoelectric 
point as determined by IEF was at pH 5.1. The en- 
zyme did not lose activity for several weeks in 40°70 
glycerol at pH 7.0 and 4°C. Addition of 
2-mercaptoethanol was beneficial to enzyme 
stability. 
The optimal pH for the hydrolysis of AIa-2NA 
in the presence of chloride ions was pH 7.6. The 
C1--activated aminopeptidase was inhibited by 
bestatin and amastatin but was resistant to leupep- 
tin and puromycin. Inhibition was also pronounc- 
Table 1 
Purification of C1--activated aminopeptidase from human 
erythrocytes 
Purification Volume Protein Spec. act. Yield 
step (ml) (mg/ml) (mU/mg) (0/0) 
Cytosol 944.0 64.40 0.066 100 
I DEAE-cellulose, 
ultrafiltration 54.5 0.25 64.72 22 
II DEAE-cellulose 6.5 0.52 250.04 21 
Sephacryl S-200 16.5 0.028 1513.30 17 
ed in the presence of 4-hydroxymercuribenzoate 
and 1,10-phenanthroline. EDTA was less potent 
and inhibited the enzyme only at a concentration 
of 10 -2 M, as lower concentrations enhanced the 
enzyme activity. The inactivation of the enzyme by 
4-hydroxymercuribenzoate was partially reversed 
by the addition of thiol compounds. Thus 4 mM 
2-mercaptoethanol or 2 mM dithiothreitol restored 
34°70 of the aminopeptidase activity. Activation by 
thiol agents was observed as well, but with the en- 
zyme which was extensively dialysed against the 
buffer without 2-mercaptoethanol. Metal ions, 
Co 2÷, Zn 2÷ and Mn 2÷ already at a concentration 
of 0.01 mM were inhibitory, whereas 1 mM Ca 2÷ 
was without effect. The hydrolysis rate of 
Ala-4Nan was also diminished in the presence of 
0.1 mM L-amino acids having hydrophobic side 
chains. 
3.3. The effect of halide ions 
The isolated aminopeptidase had higher specific 
activity in Tris-HCl buffer than in the sodium 
phosphate buffer of the same pH and similar ionic 
strength. It was shown that this difference can be 
attributed to the CI- activation of the enzyme 
(fig.lA). The effect of C1- was maximal around 
0.2 M NaCI and it was pronounced with Ala-, Leu- 
and Phe-2NA as substrates. Similar activation was 
observed upon the addition of KBr or NaF to the 
reaction mixture (fig. 1B). KI had an inhibitory ef- 
fect. No increase in the activity occurred when the 
concentration of phosphate was raised from 25 to 
100 mM. 
3.4. Enzyme specificity 
The measurement of hydrolysis rates of dif- 
ferent amino acid-2NA by isolated Cl--activated 
80 





















01 Q2 6 07 02 
NaCl (M) Satt cone (M) 
Fig.1. (A) Effect of halide ions on the activity of 
aminopeptidase from human erythrocytes in 25 mM sodium- 
phosphate buffer, pH 7.5. (A) Effect of NaCI on the rate of 
hydrolysis of (©) Ala-2NA, (e) Phe-2NA and (x) Leu-2NA. 
(B) Effect of halide ions on the rate of hydrolysis of Ala-2NA. 
aminopeptidase revealed that the enzyme prefers 
Ala-2NA to the other tested substrates and does 
not cleave Glu-, Hyp- and D-Ala-2NA (table 2). It 
was shown that Leu-, Pro- and Arg-2NA behave as 
competing inhibitors of Ala-4Nan hydrolysis. The 
enzyme did not degrade proteinase substrate 
Azocoll or N-acetyl-Ala3-4Nan, a substrate of N- 
acetylalanine aminopeptidase [15]. 
The action of isolated aminopeptidase on dif- 
ferent peptides was also tested. Under the ex- 
perimental conditions tripeptides, Ala-Ala-Ala, 
Leu-Gly-Gly and Phe-Gly-Gly, were completely 
degraded. A significant degradation of dipeptides, 
Arg-Phe, Leu-Val, Val-Val, Val-Tyr, Phe-Ala, 
Phe-Phe, and tetrapeptides, Leu-Leu-Val-Tyr and 
Table 2 
Hydrolysis of amino acid-2-naphthylamides by Cl--activated 
aminopeptidase from human erythrocytes 
Substrate Relative rate Substrate Relative rate 
(%) (%) 
Ala-2NA 100 His-2NA 3 
Phe-2NA 51 Ser-2NA 2 
Leu-2NA 48 GIy-2NA 1 
Pro-2NA 27 a-Glu-2NA 0 
Met-2NA 23 Hyp-2NA 0 
Arg-2NA 18 D-AIa-2NA 0 
Val-2NA 15 Ala-Ala-2NA 9 
Tyr-2NA 15 Ala-Phe-2NA 5 
Lys-2NA 8 
Phe4 was found too. Tuftsin, Leu-enkephalin, 
bradykinin, and angiotensins I, II and III were not 
hydrolysed at all. 
4. DISCUSSION 
Intracellular aminopeptidases are classified bn 
the basis of their substrate specificity and 
subcellular localization [1]. By its lack of specifici- 
ty toward a particular amino acid-2NA and the 
preference for alanyl derivative, the aminopep- 
tidase from human erythrocytes, described in this 
work, resembles the soluble alanyl aminopeptidase 
from human liver [13]. However, these two en- 
zymes differ in Mr, in pH optimum, in response to 
Co 2+ and puromycin, and in that which is most im- 
portant in the susceptibility o C1- activation. The 
specificity of the erythrocyte aminopeptidase is 
also similar to that of aminopeptidase from human 
skeletal muscle [16], but this enzyme isactivated by 
Ca 2+ and not by C1-. 
The halide ions stimulated soluble arginyl 
aminopeptidases isolated from several human 
tissues [2-7], and the cystinyl aminopeptidase 
from skeletal muscle [8], clearly have different 
specificities towards amino acid naphthylamides, 
than the presently described enzyme. Also, en- 
dopeptidase action found for arginyl aminopep- 
tidase [4,5,7] was not observed with the new 
Cl--activated enzyme from human erythrocytes. 
Following the criteria applied to other aminopep- 
tidases the enzyme isolated from human 
erythrocytes can be named C1--activated alanyl 
aminopeptidase. 
However, newly isolated aminopeptidase has a 
number of properties in common with other 
Cl--activated aminopeptidases. These are: the 
similar activation by halide ions, the presence of 
SH groups responsible for enzyme activity, inhibi- 
tion by bestatin and not by puromycin, inhibition 
by metal cations and by 1,10-phenanthroline, with 
low sensitivity to EDTA at the same time. Arginyl 
aminopeptidase from skeletal muscle and brain, 
muscle cystinyl aminopeptidase, and new 
aminopeptidase from erythrocytes also have 
similar Mr and monomeric structure. Thus 
Cl--activated aminopeptidases might belong to the 
same class of aminopeptidases, defined by the 
criteria not used in classification of these enzymes 
so far. 
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